Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Clinical utility of cerebrospinal fluid vitamin D-binding protein as a novel biomarker for the diagnosis of viral and bacterial CNS infections

Fig. 1

Comparison of median CSF VDBP levels and interquartile ranges (a) The difference in CSF VDBP levels between the CNS infection (3.20 μg/mL, 1.70–5.10) and non-CNS infection groups (1.10 μg/mL, 0.80–1.80)(P < 0.001). (b) The difference in CSF VDBP levels between the pathogen-identified group (2.34 μg/mL, 1.46–4.53) and non-identified group (3.76 μg/mL, 2.25–5.21)(P = 0.075) within the CNS infection group. Outliers of 1.5 to 3 IQR are marked with circles, and outliers > 3 IQR are marked with squares. Abbreviations: VDBP, vitamin D-binding protein; CNS, central nervous system; IQR, interquartile range

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us